Hormonal therapy recommended as a first-line treatment for menopausal vasomotor symptoms

The American College of Physicians (ACP) recommends estrogen successful operation with progestogen (for females with a uterus) oregon estrogen monotherapy (for females without a uterus) arsenic first-line attraction for perimenopausal and postmenopausal females experiencing menopausal vasomotor symptoms (VMS), which dwell of blistery flashes and nighttime sweats. ACP's caller objective line is published successful Annals of Internal Medicine.